Atlas Trials

Intravesical Ty21a for the Treatment of Patients With Non-muscle-invasive Bladder Cancer (NMIBC)

Clinical trial NCT03421236 · UNKNOWN

Trial details

NCT number
NCT03421236
Sponsor
Patrice Jichlinski
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Non Muscle Invasive Bladder Cancer
Start date
2018-02-18
Primary completion
2021-12-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.